SCHEMBL20599650

SCHEMBL20599650

N=C(N)c1ccc(F)c(F)c1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
KLK1 P06870 2/20 0.35
KLK5 Q9Y337 2/20 0.35
F2 P00734 3/20 0.33
F10 P00742 2/20 0.33
PLAU P00749 2/20 0.33
LMNA P02545 2/20 0.33
PLG P00747 1/20 0.33
PLAT P00750 1/20 0.33
MAP2K2 P36507 1/20 0.33
MAP2K1 Q02750 1/20 0.33
DGAT1 O75907 1/20 0.32
BCHE P06276 1/20 0.32
F12 P00748 1/20 0.32
F7 P08709 1/20 0.32
F3 P13726 1/20 0.32
PKM P14618 1/20 0.32
BLM P54132 1/20 0.31
MASP2 O00187 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555860 0.79 CES2 (0.56) CES2CES1KLK1KLK5F2
Bromide SCHEMBL8428641 0.77 LMNA (0.33) CES2CES1KLK1KLK5F2
SCHEMBL28324998 0.77 HPGD (0.44) CES2CES1F2F10LMNA
Hydrochloric Acid SCHEMBL3647753 0.77 CES2 (0.54) CES2CES1F2F10PLG
SCHEMBL12569725 0.77 HPGD (0.44) CES2CES1F2F10PLAU
SCHEMBL9555743 0.76 CES2 (0.54) CES2CES1LMNAMAP2K2MAP2K1
SCHEMBL1003016 0.76 CES2 (0.67) CES2CES1MAP2K2MAP2K1DGAT1
Hydrochloric Acid SCHEMBL10434081 0.76 CES2 (0.52) CES2CES1KLK1KLK5F2
SCHEMBL8131575 0.74 CES2 (0.56) CES2CES1KLK1KLK5F2
Hydrochloric Acid SCHEMBL14486951 0.74 LMNA (0.47) KLK1KLK5F2F10PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645516-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed
CN-101115744-B Process for preparing 4- (6-chloro-2, 3-methylenedioxyanilino) -7- [2- (4-methylpiperazin-1-yl) ethoxy ] -5-tetrahydropyran-4-yloxyquinazoline, intermediates and crystalline salts thereof ASTRAZENECA AB (SE) 2012-02-01 CN disclosed
CN-101115744-A Process for preparing 4- (6-chloro-2, 3-methylenedioxyanilino) -7- [ 2- (4-methylpiperazin-1-yl) ethoxy ] -5-tetrahydropyran-4-yloxyquinazoline, intermediates and crystalline salts thereof ASTRAZENECA AB (SE) 2008-01-30 CN disclosed